InvestorsHub Logo

ccsykes

03/27/17 12:56 PM

#1574 RE: Alan Brochstein #1565

As of 9/30, they had very little to show.



Alan, if you hadn't noticed, we're pivoting the Company because of adoption problems. This has been disclosed in interviews, SEC filings etc.. We've announced a new business strategy. Managements frustration with your coverage is that point specifically.

For the sake of your members, it might behoove you to better understand what the "entourage effect" is, how the DEA's recent policy guidance impacts the future of cannabis in the U.S. and how our technology, partnerships and past R&D have positioned us in the industry.

You say we have little to show and I believe that is quite debatable.

We're trading roughly a $16.8M pre-money now, based on the disclosures we've made as a potential pharmaceutical producer.

You should be asking not about our sales pipeline, because that is no longer key to our business plan. You should be asking if we have the wherewithal to obtain a Texas, Colorado and DEA license and to utilize our core assets to become a producer instead of an equipment company.